<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="12603">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00470626</url>
  </required_header>
  <id_info>
    <org_study_id>05-507</org_study_id>
    <secondary_id>110006, GTMX</secondary_id>
    <nct_id>NCT00470626</nct_id>
  </id_info>
  <brief_title>Celect Vena Cava Filter Clinical Trial</brief_title>
  <official_title>Prospective Study of the Cook Celect Filter, Including Permanent and Retrievable Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MED Institute, Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>William Cook Australia</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>William Cook Europe</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cook Ireland, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>Mexico: Federal Commission for Sanitary Risks Protection</authority>
    <authority>Australia: Department of Health and Ageing Therapeutic Goods Administration</authority>
    <authority>Germany: Ethics Commission</authority>
    <authority>Spain: Spanish Agency of Medicines</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical study will collect data to verify the safety and performance of the Cook Celect
      Filter in the prevention of pulmonary embolism (PE) in patients with a temporary or
      permanent high risk of thromboembolism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Major Adverse Event</measure>
    <time_frame>up to 12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Composite Major Adverse Event includes hemorrhage, perforation, pulmonary embolism, procedure-related or device-related death, occlusion, significant migration and filter fracture.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful Retrieval</measure>
    <time_frame>up to 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. A decision to remove a filter was made after determining that the patient no longer required the filter. Retrieval attempts were either successful (i.e., the filter was removed) or unsuccessful (i.e., the filter could not be removed and remained in the patient as a permanent device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Time to Retrieval Attempt</measure>
    <time_frame>up to 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mean time to retrieval describes the average time filters were in place in the study group before a retrieval attempt was made.
A retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. The mean time to retrieval describes the average time filters were in place before a retrieval attempt was made.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">129</enrollment>
  <condition>Pulmonary Embolism</condition>
  <condition>Venous Thromboembolism</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vena Cava Filter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Celect Vena Cava Filter</intervention_name>
    <description>Effective filtration of inferior vena cava blood to prevent thromboembolism.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is at high risk for pulmonary embolism and is under consideration for
             placement of a permanent or short-term IVC filter.

          -  The patient must have a patent internal jugular vein.

          -  The patient or guardian must have given informed consent.

          -  The patient must agree to return for clinical imaging follow-up at 1, 3, 6, and 12
             months.

          -  The patient must agree to have a clinical and imaging examination performed prior to
             filter retrieval.

          -  The patient must agree to return for clinical and imaging follow-up at 30 days and 3
             months after filter retrieval.

        Exclusion Criteria:

          -  The patient is less than 18 years of age.

          -  The patient is pregnant.

          -  The patient has uncontrollable coagulopathy.

          -  The patient has a life expectancy less than 6 months.

          -  The patient has a vena cava diameter over 30 mm, measured by vena cava sizing
             catheters.

          -  The patient's vena cava diameter is less than 15 mm, measured by vena cava sizing
             catheters.

          -  The patient has a contrast allergy that can not be adequately pre-medicated.

          -  The patient is simultaneously participating in another investigative drug or device
             study, or has a previous IVC filter.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R.W. Gunther, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik Fur Radiologische Diagnostik Universitaetklinikum der RWTH Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <zip>3181</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RWTH Aachen University</name>
      <address>
        <city>Aachen</city>
        <zip>D-52057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Enfermedades Respiratorias</name>
      <address>
        <city>Mexico City</city>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Nuevo Leon</name>
      <address>
        <city>Monterrey</city>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitario Zaragoza - Hospital Clinico</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Hampshire Hospital</name>
      <address>
        <city>Hampshire</city>
        <zip>RG24 9NA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <zip>LS97TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Germany</country>
    <country>Mexico</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Lyon SM, Riojas GE, Uberoi R, Patel J, Lipp ME, Plant GR, De Gregorio MA, GÃ¼nther RW, Voorhees WD, McCann-Brown JA. Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry. J Vasc Interv Radiol. 2009 Nov;20(11):1441-8. doi: 10.1016/j.jvir.2009.07.038.</citation>
    <PMID>19875061</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <lastchanged_date>December 21, 2015</lastchanged_date>
  <firstreceived_date>September 14, 2005</firstreceived_date>
  <firstreceived_results_date>February 3, 2010</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary Embolism</keyword>
  <keyword>Venous Thromboembolism</keyword>
  <keyword>Inferior Vena Cava Filter</keyword>
  <keyword>IVC</keyword>
  <keyword>PE</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Celect Vena Cava Filter</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="129"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Celect Vena Cava Filter</title>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="129"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="51" spread="19"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="58"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="71"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Cancer</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Cancer</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="23"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Cancer</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="106"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Coagulation Disorder</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Coagulation Disorder</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Coagulation Disorder</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="125"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Congestive Heart Failure (CHF)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>CHF</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No CHF</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="128"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Coronary Heart Disease (CHD)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>CHD</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No CHD</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="128"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Current Deep Venous Thrombosis (DVT)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Current DVT</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="72"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Current DVT</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Current Pulmonary Embolism (PE)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Current PE</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="50"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Current PE</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="79"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Diabetes Type I</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Diabetes Type II</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Diabetes</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="117"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gastrointestinal (GI) Disease</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>GI Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="8"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No GI Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="121"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Hepatic Disease</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hepatic Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Hepatic Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="126"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hypertension</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Hypertension</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="129"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Peripheral Vascular Disease (PVD)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>PVD</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="7"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No PVD</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="122"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Pulmonary Disease</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Pulmonary Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="33"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Pulmonary Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="96"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Renal Disease</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Renal Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Renal Disease</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="124"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Stroke</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Stroke</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="7"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Stroke</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="122"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Trauma</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Trauma</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="38"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Trauma</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="91"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Adverse Event</title>
        <description>Composite Major Adverse Event includes hemorrhage, perforation, pulmonary embolism, procedure-related or device-related death, occlusion, significant migration and filter fracture.</description>
        <time_frame>up to 12 months</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Celect Vena Cava Filter</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="129"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Major Adverse Event</title>
            <description>Composite Major Adverse Event includes hemorrhage, perforation, pulmonary embolism, procedure-related or device-related death, occlusion, significant migration and filter fracture.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Hemorrhage, Perforation</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Pulmonary Embolism</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Procedure or Device-Related Death</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Inferior Vena Cava Occlusion</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Significant Migration</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Filter Fracture</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Successful Retrieval</title>
        <description>Retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. A decision to remove a filter was made after determining that the patient no longer required the filter. Retrieval attempts were either successful (i.e., the filter was removed) or unsuccessful (i.e., the filter could not be removed and remained in the patient as a permanent device).</description>
        <time_frame>up to 12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>129 patients received a filter. Filters were placed as permanent devices in 34 patients and as temporary devices in 95 patients. A decision to retrieve a filter was made by the physician once the patientâs medical condition warranted it (once the fliter was no longer required). Filter retrieval was attempted in 58 of 95 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Celect Vena Cava Filter</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="58"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Successful Retrieval</title>
            <description>Retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. A decision to remove a filter was made after determining that the patient no longer required the filter. Retrieval attempts were either successful (i.e., the filter was removed) or unsuccessful (i.e., the filter could not be removed and remained in the patient as a permanent device).</description>
            <units>successful retrievals</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="56"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <param_type>Probability of Successful Retrieval</param_type>
            <param_value>.9</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Probability of successful retrieval is from Kaplan-Meier analysis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Time to Retrieval Attempt</title>
        <description>Mean time to retrieval describes the average time filters were in place in the study group before a retrieval attempt was made.
A retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. The mean time to retrieval describes the average time filters were in place before a retrieval attempt was made.</description>
        <time_frame>up to 12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Celect Vena Cava Filter</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="58"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Time to Retrieval Attempt</title>
            <description>Mean time to retrieval describes the average time filters were in place in the study group before a retrieval attempt was made.
A retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. The mean time to retrieval describes the average time filters were in place before a retrieval attempt was made.</description>
            <units>days</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="186" spread="124"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Celect Vena Cava Filter</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hemorrhage, Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="129"/>
              </event>
              <event>
                <sub_title>Procedure or Device Related Death</sub_title>
                <description>1 death occured within 24 hours of device placement. Poor overall health likely contributed to death.
1 death occurred 185 days post-procedure and was the result of a pulmonary thromboembolism; the location of the origin of the clot was unknown.</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Scott Snyder</name_or_title>
      <organization>Cook</organization>
      <phone>765-463-7537</phone>
      <email>ssnyder@medinst.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
